Jonathan C. Fox, See Remarks at Eidos Therapeutics, Inc. (EIDX), sold 7,040 shares at $50.00 ($250K) on 2020-06-03, disclosed to the SEC on 2020-06-05.
Open-market sale of $250k EIDX by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,020 | $0 | 0.0% |
| 2 | $0.00 | 1,020 | $0 | 0.0% |
| 3 | $50.00 | 5,000 | $250K | 100.0% |
| Total | $35.51 avg | 7,040 | $250K | 100% |
| Filing → |
| EIDX | SELL | 2020-09-18 | $579K | — | Filing → |
| EIDX | SELL | 2020-09-16 | $369K | — | Filing → |
| EIDX | SELL | 2020-07-09 | $250K | — | Filing → |